Argonaut Manufacturing Services, a contract development and manufacturing organization serving the biopharma and life sciences industries, has been selected as the manufacturing partner for Akoya Biosciences Inc.’s IVD assays currently in development.

This agreement builds on years of collaboration between Argonaut and Akoya, reflecting Argonaut’s ability to support both emerging and mature diagnostic product lines. Furthermore, this expanded collaboration underscores both companies’ commitment to advancing precision medicine through high-quality diagnostics.

“Argonaut and Akoya have built a trusted relationship over the years,” said Wayne Woodard, Founder and CEO of Argonaut. “We’ve successfully supported their Research Use only (RUO) portfolio, and we are thrilled to extend this partnership into the highly regulated companion diagnostic space. Akoya’s innovative solutions in spatial biology are shaping the future of precision medicine, and we are proud to play a role in bringing their vision to life.”

“Our spatial phenotyping technology and PhenoImager platform are demonstrating robust diagnostic capabilities for patient selection,” commented Brian McKelligon, CEO of Akoya. “Our partnership with Argonaut is centered around delivering high-quality IVD products to our clients, manufactured under strict cGMP and ISO 13485:2016 requirements. Argonaut’s deep expertise and reliable systems make them an invaluable partner as we scale to meet the demand of the market.”